Eli Lilly 2008 Annual Report Download - page 131

Download and view the complete annual report

Please find page 131 of the 2008 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 132

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132

© 2009 Eli Lilly and Company 2009AR
For More Information
Lilly corporate responsibility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . www.lilly.com/responsibility/
Lilly clinical trials registry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . www.lillytrials.com
Lilly Grant Offi ce . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . www.lillygrantoffi ce.com
LillyPAC contributions report. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
www.lilly.com/about/public_affairs/
Multidrug-Resistant Tuberculosis Partnership . . . . . . . . . . . . . . . . . www.lillymdr-tb.com
Medicare prescription drug coverage . . . . . . . . . . . . . . . . . . . . . . . . . www.lillymedicareanswers.com
Pharmaceutical industry patient assistance programs . . . . . . . . . . www.pparx.org
Lilly Cares. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . www.lillycares.com or call toll-free 1-800-545-6962
Trademarks
Actos® (pioglitazone hydrochloride)
Alimta® (pemetrexed disodium)
Byetta® (exenatide injection)
Ceclor™ (cefaclor)
Cialis® (tadalafi l)
Coban® (monensin sodium), Elanco
Comfortis® (spinosad), Elanco
Cymbalta® (duloxetine hydrochloride)
Effi ent™ (prasugrel)
Efi ent™ (prasugrel)
Erbitux® (cetuximab)
Evista® (raloxifene hydrochloride)
Forsteo® (teriparatide of recombinant DNA origin)
Forteo® (teriparatide of recombinant DNA origin)
Gemzar® (gemcitabine hydrochloride)
Humalog® (insulin lispro of recombinant DNA origin)
HumaPen® Luxura HD™ (insulin lispro injection, USP (rDNA origin))
Humatrope® (somatropin of recombinant DNA origin)
Humulin® (human insulin of recombinant DNA origin)
KwikPen™ (insulin lispro injection, (rDNA origin))
Posilac® (sometribove), Elanco
Prozac® (fl uoxetine hydrochloride)
Prozac® Weekly™ (fl uoxetine hydrochloride)
ReoPro® (abciximab), Centocor
Rumensin® (monensin sodium), Elanco
Strattera® (atomoxetine hydrochloride)
Symbyax® (olanzapine/fl uoxetine hydrochloride)
Tyla n® (tylosin), Elanco
Vancocin® (vancomycin hydrochloride)
Xigris® (drotrecogin alfa [activated])
Yent re ve™ (duloxetine hydrochloride)
Zypadherea™ (olanzapine)
Zyprexa® (olanzapine)
Zyprexa® Zydis® (olanzapine)
Actos® is a trademark of Takeda Chemical Industries, Ltd.
AIR® is a trademark of Alkermes, Inc.
Axid® is a trademark of Reliant Pharmaceuticals, LLC
Byetta® is a trademark of Amylin Pharmaceuticals, Inc.
Erbitux® is a trademark of ImClone LLC
Vancocin® is a trademark of ViroPharma Incorporated
Zydis® is a trademark of Cardinal Health.
All trademarks listed above are trademarks of Eli Lilly and Company unless otherwise noted.